Follow our schedule to connect with CHERISH researchers and colleagues attending the 2025 Society for Epidemiologic Research Conference. View the full program online.

Follow the itinerary below to connect with CHERISH researchers and colleagues attending AcademyHealth's Annual Research Conference. View the full conference program on their website.

Connect with CHERISH Research Affiliates, Advisory Board members, and pilot grant recipients in person as they present their research at #ASHEcon2025.

The Society for Medical Decision Making (SMDM) North American Meeting brings together high-quality oral and poster presentations, short courses, symposia presentations, and workshops from all disciplines involved in the study of decision making in health and medicine. Connect with CHERISH researchers and colleagues attending this year and view the full program online.

Follow the itinerary below to connect with CHERISH researchers and colleagues attending #CPDD25 or view the full conference program on their website.

This free virtual workshop, open to all, includes a robust agenda that demonstrates how health economics research informs treatment and care for people with substance use disorder, mental health illnesses, and related conditions. Co-led by NIH HEAL Initiative, the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), the half-day workshop and forum features multidisciplinary experts in health economics and health services research, including CHERISH investigators Yuhua Bao, Sean M. Murphy, and Bruce Schackman; CHERISH Research Affiliates Todd Olmstead, Erica Crable, Beth McGinty, and Catherine Maclean; and former pilot grant recipient Sierra Castedo De Martell. Researchers, advocacy organizations, health system and community treatment providers, federal partners, policymakers, individuals with lived or living experience with substance use disorder and serious mental illness, and others interested in supporting cost-effective and quality care are welcome to attend, connect with the panelists, and share research priorities to consider.

In recent decades, countless new synthetic drugs have entered the underground drug supply, and overdose deaths and other drug-related harms have skyrocketed as a result. Media, policymakers, and the general public are concerned — but often misguided — in their attempts to address the issue because they lack accurate information about drugs and drug supply changes. This four-part series will explore the most commonly used new and emerging synthetic drugs in the United States, the geographic trends in where and when these drugs have spread, and the demographic trends in who is impacted by these drugs. Panelists will examine the risks and harms faced by people who use drugs and discuss the role of harm reduction and medical providers in reducing overdose and health risks. We know that current drug policies fuel and will continue to incentivize new, and likely, more dangerous drugs. We will envision solutions that are just as innovative and nimble as these new markets. Join this new series starting in March: March 13, 2025 | 3:00pm – 5:00pm ET | Keynote and Panel 1: Understanding the Current Drug Supply (Recording) April 10, 2025 | 3:30pm – 5:00pm ET | Panel 2: Addressing Myths, Misinformation, and Real Harms (Recording) May 8, 2025 | 3:30pm – 5:00pm ET | Panel 3: Understanding Drug Markets (Recording) May 29, 2025 | 3:00pm – 5:00pm ET | Panel 4: Scaling Up Drug Checking, Envisioning Safe Supply, and Exploring New Horizons